Lineage, Inc. Common Stock (LINE)vsTPG RE Finance Trust Inc (TRTX)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
TRTX
TPG RE Finance Trust Inc
$7.42
-0.80%
REAL ESTATE · Cap: $603.02M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 3961% more annual revenue ($5.37B vs $132.25M). TRTX leads profitability with a 43.9% profit margin vs -3.1%. TRTX earns a higher WallStSmart Score of 52/100 (C-).
LINE
Avoid35
out of 100
Grade: F
TRTX
Buy52
out of 100
Grade: C-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Keeps 44 of every $100 in revenue as profit
Strong operational efficiency at 43.5%
Attractively priced relative to earnings
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Smaller company, higher risk/reward
ROE of 5.6% — below average capital efficiency
Weak financial health signals
Revenue declined 11.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : TRTX
The strongest argument for TRTX centers on Price/Book, Profit Margin, Operating Margin. Profitability is solid with margins at 43.9% and operating margin at 43.5%.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : TRTX
The primary concerns for TRTX are Market Cap, Return on Equity, Piotroski F-Score. Debt-to-equity of 3.36 is elevated, increasing financial risk.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while TRTX is a declining play — different risk/reward profiles.
TRTX carries more volatility with a beta of 1.47 — expect wider price swings.
LINE is growing revenue faster at 0.8% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
TRTX scores higher overall (52/100 vs 35/100), backed by strong 43.9% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →TPG RE Finance Trust Inc
REAL ESTATE · REIT - MORTGAGE · USA
TPG RE Finance Trust, Inc., a commercial real estate finance company, originates, acquires and manages commercial mortgage loans and other commercial real estate-related debt instruments in North America. The company is headquartered in New York, New York.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?